SM-86(Lipid 5)
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
MeTis Lipid 1 is an ionizable lipid featuring a pentacyclic core with geminal dimethyl groups and symmetrical C9 alkyl chains developed by Metis Pharm. According to Patent WO 2025/140421 A1, Lipid 1 demonstrated exceptional biological performance including: the highest SARS-CoV-2 neutralization titer (NT50 1:2146, 5.7-fold higher than ALC0315), potent humoral immunity with COVID-19 IgG titers reaching 1:1,000,000 post-boost and exclusive validation for VZV-gE IgG (1:1,000,000), favorable biophysical properties (124.5 nm LNP diameter, 0.2 PDI, 85% encapsulation efficiency), and excellent safety profile (hERG IC₅₀ >30 μM, Mini-Ames negative), establishing it as the lead compound in nucleic acid vaccine delivery.
| CAS No. | Not available |
| Chemical Name | MeTis Lipid 1 |
| Synonyms | MeTis Lipid-1 |
| SMILES | CCCCCCCCCC(=O)OCC(C)(C)CCCCC(CCCCC(C)(C)COC(=O)CCCC(CCCCC)CCCCC)OC(=O)CCCN(C)C |
| Formula | C48H93O6N |
| M.Wt | 780.27 |
| Purity | >98% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 12.8161 mL | 2.5632 mL | 1.2816 mL |
| 25 mg | 32.0402 mL | 6.4080 mL | 3.2040 mL |
| 50 mg | 64.0804 mL | 12.8161 mL | 6.4080 mL |
| 100 mg | 128.1608 mL | 25.6322 mL | 12.8161 mL |
| 250 mg | 320.4019 mL | 64.0804 mL | 32.0402 mL |
Contact our team with the catalog number and requested quantity.